01 Sep 2017 – Destiny Pharma plc publishes Supplementary AIM Admission Document

Destiny Pharma plc today published a Supplementary AIM Admission document in respect of the admission to trading on AIM of its entire ordinary share capital, which is expected to take place at 8.00am on Monday, 4 September 2017. The Supplementary Admission Document can be found here.